These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6314737)

  • 1. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
    Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
    Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
    Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
    Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
    Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
    Hirschman GH; DeLuca HF; Chan JC
    Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophosphatemic vitamin D resistant rickets treatment with one alpha hydroxy vitamin D3.
    Tragler A; Pai BU
    Indian Pediatr; 1989 Apr; 26(4):386-8. PubMed ID: 2557284
    [No Abstract]   [Full Text] [Related]  

  • 7. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphataemic vitamin-D resistant rickets may need phosphate supplements.
    Price HV; Woodhead JS
    Br Med J (Clin Res Ed); 1982 May; 284(6327):1442-3. PubMed ID: 6282378
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A report on two siblings with vitamin D resistant rickets treated with 1 alpha-hydroxy-vitamin D3 until completion of the growth].
    Yoshikawa S; Ohno A; Amagai H; Ikeda K
    Nihon Seikeigeka Gakkai Zasshi; 1992 Nov; 66(11):1137-45. PubMed ID: 1336532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypophosphataemic vitamin D-resistant rickets.
    Kristiansen JH; Pedersen VF
    Arch Dis Child; 1981 Jan; 56(1):76-7. PubMed ID: 6258488
    [No Abstract]   [Full Text] [Related]  

  • 16. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rickets with alopecia-remission following a course of 1-alpha-hydroxy vitamin D3 therapy.
    Manandhar DS; Sarkawi S; Hunt MC
    Eur J Pediatr; 1989 Aug; 148(8):761-3. PubMed ID: 2551693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.